Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'coronary intervention' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 204 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Sdringola, S; Assali, AR; Ghani, M; Moustapha, A; Achour, H; Yusuf, SW; Fujise, K; Rosales, O; Schroth, GW; Anderson, HV; Smalling, RW
      Risk assessment of slow or no-reflow phenomenon in aortocoronary vein graft percutaneous intervention

      CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS
    2. Schobel, WA; Spyridopoulos, I; Hoffmeister, HM; Seipel, L
      Percutaneous coronary interventions using a new 5 french guiding catheter:Results of a prospective study

      CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS
    3. Terashima, M; Meguro, T; Takeda, H; Endoh, N; Ito, Y; Mitsuoka, M; Ohtomo, T; Murai, O; Fujiwara, S; Honda, H; Miyazaki, Y; Kuhara, R; Kawashima, O; Isoyama, S
      Percutaneous ulnar artery approach for coronary angiography: A preliminaryreport in nine patients

      CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS
    4. Fram, DB; Giri, S; Jamil, G; Mitchel, JF; Boden, WE; Din, S; Kiernan, FJ
      Suture closure of the femoral arteriotomy following invasive cardiac procedures: A detailed analysis of efficacy, complications, and the impact of early ambulation in 1,200 consecutive, unselected cases

      CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS
    5. Saito, S
      Transradial approach - From the evangelist's view

      CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS
    6. Simon, DI; Liu, CB; Ganz, P; Kirshenbaum, JM; Piana, RN; Rogers, C; Selwyn, AP; Popma, JJ
      A comparative study of light transmission aggregometry and automated bedside platelet function assays in patients undergoing percutaneous coronary intervention and receiving abciximab, eptifibatide, or tirofiban

      CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS
    7. Dippel, EJ; Kereiakes, DJ; Tramuta, DA; Broderick, TM; Shimshak, TM; Roth, EM; Hattemer, CR; Runyon, JP; Whang, DD; Schneider, JF; Abbottsmith, CW
      Coronary perforation during percutaneous coronary intervention in the era of abciximab platelet glycoprotein IIb/IIIa blockade: An algorithm for percutaneous management

      CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS
    8. Grantham, JA; Tiede, DJ; Holmes, DR
      Technical considerations when intervening with coronary device catheters in the vicinity of previously deployed stents

      CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS
    9. Rothman, MT; Serruys, PW; Grollier, G; Hoorntje, JCA; van den Bos, AA; Wijns, W; Gershlick, AH; Van Es, GA; Melkert, R; Eijgelshoven, MHJ; Lenderink, TT; Richardson, G; Dille-Amo, C
      Angiographic and clinical one-year follow-up of the Cordis tantalum coil stent in a multicenter international study demonstrating improved restenosisrates when compared to pooled PTCA and BENESTENT-I data: The European Antiplatelet Stent Investigation (EASI)

      CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS
    10. Carey, D; Martin, JR; Moore, CA; Valentine, M; Nygaard, TW
      Complications of femoral artery closure devices

      CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS
    11. Hod, HH; Kleiman, NS; Sequeira, RF; Voipio-Pulkki, LM
      Issues in cardiac intervention for UA/NSTEMI

      EUROPEAN HEART JOURNAL SUPPLEMENTS
    12. Lindahl, B
      Detection of myocardial damage - are the troponins the ultimate solution?

      SCANDINAVIAN CARDIOVASCULAR JOURNAL
    13. Gaster, AL; Slothuus, U; Larsen, J; Thayssen, P; Haghfelt, T
      Cost-effectiveness analysis of intravascular ultrasound guided percutaneous coronary intervention versus conventional percutaneous coronary intervention

      SCANDINAVIAN CARDIOVASCULAR JOURNAL
    14. Benenati, J; Shlansky-Goldberg, R; Meglin, A; Seidl, E
      Thrombolytic and antiplatelet therapy in peripheral vascular disease with use of reteplase and/or abciximab - The SCVIR Consultants' Conference; May 22, 2000; Orlando, FL

      JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY
    15. Jeong, MH; Ahn, YK; Park, JC; Ahn, BH; Na, KJ; Kim, NH; Kim, KH; Cho, JG; Park, JC; Kim, SH; Kang, JC
      A case of successful primary coronary intervention for the total occlusionof left main stem with the aid of Abciximab

      JOURNAL OF KOREAN MEDICAL SCIENCE
    16. Lucore, CL; Trask, RV; Mishkel, GJ; Rocha-Singh, KJ; Shelton, ME; Mikell, FL; Ligon, RW
      Impact of abciximab and coronary stenting on outcomes and costs of percutaneous coronary interventions in a community hospital

      CORONARY ARTERY DISEASE
    17. Kereiakes, DJ; Lorenz, T; Young, JJ; Kukielka, G; Mueller, MN; Nanniazzi-Alaimo, L; Phillips, DR
      Differential effects of citrate versus PPACK anticoagulation on measured platelet inhibition by abciximab, eptifibatide and tirofiban

      JOURNAL OF THROMBOSIS AND THROMBOLYSIS
    18. Matzdorff, AC; Kuhnel, G; Kemkes-Matthes, B; Voss, R
      Comparison of GP IIB/IIIA inhibitors and their activity as measured by aggregometry, flow cytometry, single platelet counting, and the rapid plateletfunction analyzer

      JOURNAL OF THROMBOSIS AND THROMBOLYSIS
    19. Kimmelstiel, C; Phang, R; Rehman, A; Rand, W; Miele, R; Rhofiry, J; MacIsaac, DA; Gouveia, W; Denier, D; Becker, RC
      Short-term comparative outcomes associated with the use of GP IIb/IIIa antagonists in patients undergoing coronary intervention

      JOURNAL OF THROMBOSIS AND THROMBOLYSIS
    20. Choo, JK; Kereiakes, DJ
      Low molecular weight heparin therapy for percutaneous coronary intervention: A practice in evolution

      JOURNAL OF THROMBOSIS AND THROMBOLYSIS
    21. Proimos, G
      Platelet aggregation inhibition with glycoprotein IIb-IIIa inhibitors

      JOURNAL OF THROMBOSIS AND THROMBOLYSIS
    22. Lev, EI; Osende, JI; Richard, MF; Robbins, JA; Delfin, JA; Rodriguez, O; Sharma, SK; Jayasundera, T; Badimon, JJ; Marmur, JD
      Administration of abciximab to patients receiving tirofiban or eptifibatide: Effect on platelet function

      JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
    23. Rossi, F; Rossi, E; Pareti, FI; Colli, S; Tremoli, E; Gallo, L
      In vitro measurement of platelet glycoprotein IIb/IIIa receptor blockade by abciximab: interindividual variation and increased platelet secretion

      HAEMATOLOGICA
    24. Niessner, A; Niessner, H; Huber, K
      Antithrombotic therapy in unstable angina and after coronary interventions

      HERZ
    25. Nicholson, NS; Abood, NA; Panzer-Knodle, SG; Frederick, LG; Page, JD; Salyers, AK; Suleymanov, OD; Szalony, JA; Taite, BB; Anders, RJ
      Orbofiban: An orally active GPIIB/IIIa platelet receptor antagonist

      MEDICINAL RESEARCH REVIEWS
    26. Fry, ETA
      Glycoprotein IIb/IIIa inhibitors and low-molecular-weight heparins: A combined role in coronary interventions?

      CLINICAL CARDIOLOGY
    27. Sugiura, T; Yamasaki, F; Hatada, K; Nakamura, S; Iwasaka, T
      Correlates of bundle-branch block in patients undergoing primary angioplasty for acute myocardial infarction

      CLINICAL CARDIOLOGY
    28. Qureshi, AI; Ali, Z; Suri, MFK; Kim, SH; Fessler, RD; Ringer, AJ; Guterman, LR; Hopkins, LN
      Open-label phase I clinical study to assess the safety of intravenous eptifibatide in patients undergoing internal carotid artery angioplasty and stent placement

      NEUROSURGERY
    29. Haumer, M; Atteneder, M; Ahmadi, R; Schillinger, M; Minar, E
      Coadministration of low-dose urokinase and abciximab in thrombolysis for lower limb ischemia - A safety study

      THROMBOSIS RESEARCH
    30. Shihara, M; Tsutsui, H; Tsuchihashi, M; Shigematsu, H; Yamamoto, S; Koike, G; Kono, S; Takeshita, A
      Coronary revascularization in Japan - Part 1: Survey of facilities during 1997

      JAPANESE CIRCULATION JOURNAL-ENGLISH EDITION
    31. Tsuchihashi, M; Tsutsui, H; Shihara, M; Shigematsu, H; Yamamoto, S; Koike, G; Kono, S; Takeshita, A
      Coronary revascularization in Japan - Part 2: Comparison of facilities between 1997 and 1999

      JAPANESE CIRCULATION JOURNAL-ENGLISH EDITION
    32. Fintel, DJ
      From bench to bedside - GP IIb-IIIa inhibitors

      NEUROLOGY
    33. Bogousslavsky, J; Leclerc, JR
      Platelet glycoprotein IIb/IIIa antagonists for acute ischemic stroke

      NEUROLOGY
    34. Zoldhelyi, P; Chen, ZQ; Shelat, HS; McNatt, JM; Willerson, JT
      Local gene transfer of tissue factor pathway inhibitor regulates intimal hyperplasia in atherosclerotic arteries

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    35. Napoli, C; Cirino, G; Del Soldato, P; Sorrentino, R; Sica, V; Condorelli, M; Pinto, A; Ignarro, LJ
      Effects of nitric oxide-releasing aspirin versus aspirin on restenosis in hypercholesterolemic mice

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    36. Kitamura, S; Fukushi, H; Miyawaki, T; Kawamura, M; Konishi, N; Terashita, Z; Naka, T
      Potent dibasic GPIIb/IIIa antagonists with reduced prolongation of bleeding time: Synthesis and pharmacological evaluation of 2-oxopiperazine derivatives

      JOURNAL OF MEDICINAL CHEMISTRY
    37. Shigeyama, J; Ito, S; Kondo, H; Ito, O; Matsushita, T; Okamoto, M; Toyama, J; Ban, Y; Fukutomi, T; Itoh, M
      Angiographic classification of coronary dissections after plain old balloon angioplasty for prediction of regression at follow-up

      JAPANESE HEART JOURNAL
    38. Sabatine, MS; Braunwald, E
      Will diabetes save the platelet blockers?

      CIRCULATION
    39. Costa, MA; Carere, RG; Lichtenstein, SV; Foley, DP; de Valk, V; Lindenboom, W; Roose, PCH; van Geldorp, TR; Macaya, C; Castanon, JL; Fernandez-Avilez, F; Gonzales, JH; Heyer, G; Unger, F; Serruys, PW
      Incidence, predictors, and significance of abnormal cardiac enzyme rise inpatients treated with bypass surgery in the Arterial Revascularization Therapies Study (ARTS)

      CIRCULATION
    40. Kitamura, S; Fukushi, H; Miyawaki, T; Kawamura, M; Terashita, Z; Naka, T
      Orally active GPIIb/IIIa antagonists: Synthesis and biological activities of masked amidines as prodrugs of 2-[(3S)-4-[(2S)-2-(4-amidinobenzoylanlino)-3-(4-methoxyphenyl)propanoyl]-3-(2-methoxy-2-oxoethyl)-2-oxopiperazinyl]acetic acid

      CHEMICAL & PHARMACEUTICAL BULLETIN
    41. Mousa, SA; Bozarth, JM; Naik, UP; Slee, A
      Platelet GPIIb/IIIa binding characteristics of small molecule RGD mimetic:distinct binding profile for Roxifiban

      BRITISH JOURNAL OF PHARMACOLOGY
    42. Lages, B; Weiss, HJ
      Greater inhibition of platelet procoagulant activity by antibody-derived glycoprotein IIb-IIIa inhibitors than by peptide and peptidomimetic inhibitors

      BRITISH JOURNAL OF HAEMATOLOGY
    43. Dillon, WC; Hadian, D; Ritchie, ME
      Refractory no-reflow successfully treated with local infusion of high-doseadenosine and verapamil - A case report

      ANGIOLOGY
    44. Hongo, RH; Brent, BN
      Association of eptifibatide and acute profound thrombocytopenia

      AMERICAN JOURNAL OF CARDIOLOGY
    45. Kini, A; Reich, D; Marmur, JD; Mitre, CA; Sharma, SK
      Reduction in periprocedural enzyme elevation by abciximab after rotationalatherectomy of type B-2 lesions: Results of the Rota ReoPro randomized trial

      AMERICAN HEART JOURNAL
    46. Antoniucci, D; Valenti, R; Migliorini, A; Moschi, G; Bolognese, L; Cerisano, G; Buonamici, P; Santoro, GM
      Direct infarct artery stenting without predilation and no-reflow in patients with acute myocardial infarction

      AMERICAN HEART JOURNAL
    47. Schneiderman, J; Morag, B; Gerniak, A; Rimon, U; Varon, D; Seligsohn, U; Shotan, A; Adar, R
      Abciximab in carotid stenting for postsurgical carotid restenosis: Intermediate results

      JOURNAL OF ENDOVASCULAR THERAPY
    48. Sdringola, S; Assali, A; Ghani, M; Yepes, A; Rosales, O; Schroth, GW; Fujise, K; Anderson, HV; Smalling, RW
      Adenosine use during aortocoronary vein graft interventions reverses but does not prevent the slow-no reflow phenomenon

      CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS
    49. Lotan, C; Dong, SH
      The no-reflow phenomenon: A light at the end of the tunnel?

      CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS
    50. Katritsis, D; Efstathopoulos, E; Betsou, S; Korovesis, S; Faulkner, K; Panayiotakis, G; Webb-Peploe, MM
      Radiation exposure of patients and coronary arteries in the stent era: A prospective study

      CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS
    51. Abernethy, WB; Choo, JK; Oesterle, SN; Jang, IK
      Balloon deflection technique: A method to facilitate entry of a balloon catheter into a deployed stent

      CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS
    52. Hojo, Y; Ikeda, U; Katsuki, T; Mizuno, O; Fukazawa, H; Kurosaki, K; Fujikawa, H; Shimada, K
      Release of endothelin 1 and angiotensin II induced by percutaneous transluminal coronary angioplasty

      CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS
    53. Jeong, MH; Kim, SH; Ahn, YK; Cho, JG; Park, JC; Na, KJ; Kang, JC
      Predictive factors for the second restenosis after coronary interventions

      CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS
    54. Steiner, MA; Marshall, JJ
      Coronary sinus compression as a sign of cardiac tamponade

      CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS
    55. Laskey, WK; Kimmel, S; Krone, RJ
      Contemporary trends in coronary intervention: A report from the Registry of the Society for Cardiac Angiography and Interventions

      CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS
    56. Mak, KH; Effron, MB; Moliterno, DJ
      Platelet glycoprotein IIb/IIIa receptor antagonists and their use in elderly patients

      DRUGS & AGING
    57. Hilleman, DE
      New approaches to the management of AMI: Fibrinolysis plus GP IIb/IIIa receptor blockade

      FORMULARY
    58. Mousa, SA; Khurana, S; Forsythe, MS
      Comparative in vitro efficacy of different platelet glycoprotein IIb/IIIa antagonists on platelet-mediated clot strength induced by tissue factor with use of thromboelastography - Differentiation among glycoprotein IIb/IIIa antagonists

      ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    59. Chauhan, MS; Carrozza, JP
      Stenting for saphenous vein graft disease: Have we solved the problem?

      JOURNAL OF INVASIVE CARDIOLOGY
    60. Mager, A; Sclarovsky, S; Herz, I; Adler, Y; Strasberg, B; Birnbaum, Y
      Value of the initial electrocardiogram in patients with inferior-wall acute myocardial infarction for prediction of multivessel coronary artery disease

      CORONARY ARTERY DISEASE
    61. Hirsch, H; Lazar, J; Marzo, KP; Steingart, RM
      Percutaneous revascularization for unstable angina in the elderly

      CORONARY ARTERY DISEASE
    62. Cannon, CP
      Bridging the gap with new strategies in acute ST elevation myocardial infarction: Bolus thrombolysis, glycoprotein IIb/IIIa inhibitors, combination therapy, percutaneous coronary intervention, and "facilitated" PCI

      JOURNAL OF THROMBOSIS AND THROMBOLYSIS
    63. Mukherjee, D; Moliterno, DJ
      Applications of anti-platelet monitoring in catheterization laboratory

      JOURNAL OF THROMBOSIS AND THROMBOLYSIS
    64. Kalra, A; Jang, IK
      Prevalence of early left ventricular thrombus after primary coronary intervention for acute myocardial infarction

      JOURNAL OF THROMBOSIS AND THROMBOLYSIS
    65. Tiede, DJ; Brady, PA; Garratt, KN; Holmes, DR
      Resolution of the "no-reflow" phenomenon with intracoronary administrationof adenosine

      JOURNAL OF INTERVENTIONAL CARDIOLOGY
    66. Humphries, KH; Rankin, JM; Carere, RG; Buller, CE; Kiely, FM; Spinelli, JJ
      Co-morbidity data in outcomes research - Are clinical data derived from administrative databases a reliable alternative to chart review?

      JOURNAL OF CLINICAL EPIDEMIOLOGY
    67. Heino, T; Kallio, K; Jokinen, E; Lagstrom, H; Seppanen, R; Valimaki, I; Viikari, J; Ronnemaa, T; Simell, O
      Sodium intake of 1 to 5-year-old children: the STRIP Project

      ACTA PAEDIATRICA
    68. Hoekstra, J
      Glycoprotein IIB/IIIA receptor inhibitor use in unstable angina/non-ST-segment elevation myocardial infarction: An appropriate-use model for the emergency department

      JOURNAL OF EMERGENCY MEDICINE
    69. Chew, DP; Moliterno, DJ
      A critical appraisal of platelet glycoprotein IIb/IIIa inhibition

      JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
    70. Angelini, P; Vaughn, WK; Zaqqa, M; Wilson, JM; Fish, RD
      Impact of the "Stent-when-feasible" policy on in-hospital and 6-month success and complication rates after coronary angioplasty: Single-center experience with 17,956 revascularization procedures (1993-1997)

      TEXAS HEART INSTITUTE JOURNAL
    71. Ikari, Y; Yee, KO; Schwartz, SM
      Role of alpha 5 beta 1 and alpha v beta 3 integrins on smooth muscle cell spreading and migration in fibrin gels

      THROMBOSIS AND HAEMOSTASIS
    72. Furman, MI; Krueger, LA; Frelinger, AL; Barnard, MR; Mascelli, MA; Nakada, MT; Michelson, AD
      GPIIb-IIIa antagonist-induced reduction in platelet surface factor V/Va binding and phosphatidylserine expression in whole blood

      THROMBOSIS AND HAEMOSTASIS
    73. Ikari, Y; Yee, KO; Hatsukami, TS; Schwartz, SM
      Human carotid artery smooth muscle cells rarely express alpha v beta 3 integrin at sites of recent plaque rupture

      THROMBOSIS AND HAEMOSTASIS
    74. Mukherjee, D; Moliterno, DJ
      Monitoring antiplatelet therapy - What is the best method?

      CLINICAL PHARMACOKINETICS
    75. Wittke, B; Ensor, H; Chung, J; Birnbock, H; Lausecker, B; Ertel, SI; Mackie, IJ; Machin, SJ
      Pharmacokinetics and pharmacodynamics of sibrafiban alone or in combination with ticlopidine and aspirin

      BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
    76. Maehara, A; Fitzgerald, PJ
      Coronary calcification: assessment by intravascular ultrasound imaging

      ZEITSCHRIFT FUR KARDIOLOGIE
    77. Amin, FR; Yousufuddin, M; Stables, R; Shamim, W; Al-Nasser, F; Coats, AJS; Clague, J; Sigwart, U
      Femoral haemostasis after transcatheter therapeutic intervention: a prospective randomised study of the angio-seal device vs. the femostop device

      INTERNATIONAL JOURNAL OF CARDIOLOGY
    78. King, SB
      Optimizing antiplatelet therapy in coronary interventions

      CLINICAL CARDIOLOGY
    79. Topol, EJ
      The future of antiplatelet therapy: Optimizing management in patients withacute coronary syndrome

      CLINICAL CARDIOLOGY
    80. Arntz, HR
      The role of prehospital thrombolysis in the treatment of acute myocardial infarction

      WIENER KLINISCHE WOCHENSCHRIFT
    81. Lqbal, O; Walenga, JM; Lewis, BE; Bakhos, M
      Bleeding complications with glycoprotein llb/llla inhibitors

      DRUGS OF TODAY
    82. Verstraete, M
      Synthetic inhibitors of platelet glycoprotein IIb/IIIa in clinical development

      CIRCULATION
    83. Silvestry, SC; Smith, PK
      Current status of cardiac surgery in the abciximab-treated patient

      ANNALS OF THORACIC SURGERY
    84. Schweizer, J; Kirch, W; Koch, R; Muller, A; Hellner, G; Forkmann, L
      Short- and long-term results of abciximab versus aspirin in conjunction with thrombolysis for patients with peripheral occlusive arterial disease andarterial thrombosis

      ANGIOLOGY
    85. Ambrose, JA; Hawkey, M; Badimon, JJ; Coppola, J; Geagea, JP; Rentrop, KP; Domiguez, A; Duvvuri, S; Elmquist, T; Arias, J; Doss, R; Dangas, G
      In vivo demonstration of an antithrombin effect of Abciximab

      AMERICAN JOURNAL OF CARDIOLOGY
    86. Kereiakes, DJ; Runyon, JP; Broderick, TM; Shimshak, TM
      IIb's are not IIb's

      AMERICAN JOURNAL OF CARDIOLOGY
    87. Mukherjee, D; Moliterno, DJ
      Achieving tissue-level perfusion in the setting of acute myocardial infarction

      AMERICAN JOURNAL OF CARDIOLOGY
    88. Moliterno, DJ; Mukherjee, D
      Applications of monitoring platelet glycoprotein IIb/IIIa antagonism and low molecular weight heparins in cardiovascular medicine

      AMERICAN HEART JOURNAL
    89. Gimelli, G; Kalra, A; Sabatine, MS; Jang, IK
      Primary versus rescue percutaneous corollary intervention in patients withacute myocardial infarction

      ACTA CARDIOLOGICA
    90. Kini, A; Kini, S; Marmur, JD; Bertea, T; Dangas, G; Cocke, TP; Sharma, SK
      Incidence and mechanism of creatine kinase-MB enzyme elevation after coronary intervention with different devices

      CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS
    91. Shaknovich, A; Forman, ST; Parikh, MA; Deutsch, E; Bergman, GW; McCaffrey, TA; Newman, GC; Tarazona, N; Sanborn, TA
      Novel distal occluder washout method for prevention of no-reflow during stenting of saphenous vein grafts

      CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS
    92. Heldman, AW; Brinker, JA
      Yes reflow

      CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS
    93. Oesterle, SN; Limpijankit, T; Yeung, AC; Stertzer, S; Pomerantsev, E; Yock, PG; Fitzgerald, PJ
      Ultrasound logic: The value of intracoronary imaging for the interventionist

      CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS
    94. Oesterle, SN; Hayase, M; Baim, DS; Teirstein, PS; Ramee, SR; Whitlow, PL; Webb, J; Virmani, R
      An embolization containment device

      CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS
    95. Honda, Y; Yock, PG; Fitzgerald, PJ
      Impact of residual plaque burden on clinical outcomes of coronary interventions

      CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS
    96. Gao, W; Koh, TH
      Retrograde embolization during saphenous vein graft angioplasty

      CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS
    97. Fox, KAA
      Comparing trials of glycoprotein IIb/IIIa receptor antagonists

      EUROPEAN HEART JOURNAL SUPPLEMENTS
    98. Simoons, ML
      New findings from the PURSUIT study

      EUROPEAN HEART JOURNAL SUPPLEMENTS
    99. Beyar, R; Tschoepe, D
      Platelet GP IIb/IIIa receptors: the new target in cardiovascular medicine - Foreword

      EUROPEAN HEART JOURNAL SUPPLEMENTS
    100. Jordan, R; Mascelli, MA
      Pharmacological differentiation of GP IIb/IIIa inhibitors

      EUROPEAN HEART JOURNAL SUPPLEMENTS


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 28/02/20 alle ore 14:20:48